Q-Med AB is a biotechnology company based in Uppsala, Sweden. Established in 1987, the company specializes in the development and manufacturing of medical devices and pharmaceutical products, particularly in the field of aesthetic medicine and regenerative medicine. Q-Med is known for its innovative use of hyaluronic acid, a substance naturally found in the body, which is utilized in various applications including dermal fillers and other therapeutic products.
The company has a strong focus on research and development, aiming to advance medical technology and improve patient outcomes. Q-Med has contributed to the field of aesthetic treatments through its product lines, which are designed to enhance facial volume and hydration. Over the years, the company has expanded its portfolio and has established a presence in various international markets, collaborating with healthcare professionals to ensure the effective application of its products.
Q-Med AB has been recognized for its commitment to quality and safety in the development of its products, adhering to stringent regulatory standards. The company continues to invest in innovation and seeks to address emerging needs within the healthcare sector, maintaining its position as a notable entity in the biotechnology industry.